On Invalid Date, Vir Biotechnology (NASDAQ: VIR) reported Q4 2023 earnings per share (EPS) of -$0.86, up 11.69% year over year. Total Vir Biotechnology earnings for the quarter were -$115.97 million. In the same quarter last year, Vir Biotechnology's earnings per share (EPS) was -$0.77.
As of Q1 2024, Vir Biotechnology's earnings has grown year over year. Vir Biotechnology's earnings in the past year totalled -$615.06 million.
What is VIR's earnings date?
Vir Biotechnology's earnings date is Invalid Date. Add VIR to your watchlist to be reminded of VIR's next earnings announcement.
What was VIR's revenue last quarter?
On Invalid Date, Vir Biotechnology (NASDAQ: VIR) reported Q4 2023 revenue of $16.79 million up 66.03% year over year. In the same quarter last year, Vir Biotechnology's revenue was $49.41 million.
What was VIR's revenue growth in the past year?
As of Q1 2024, Vir Biotechnology's revenue has grown -94.67% year over year. This is 263.96 percentage points lower than the US Biotechnology industry revenue growth rate of 169.3%. Vir Biotechnology's revenue in the past year totalled $86.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.